Where does VALIA rank among its competitors?

VALIA ranks 1176th amongst 1138 active competitors, of which 62 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Xenter, which secured $58.2M in Jun, 2026.

Who are the top competitors of VALIA?

VALIA's top competitors include Brainomix, Viz.ai and Infervision. Among them, Xenter secured the most recent funding round in June, 2026.

VALIA - 2026 Company Profile & Competitors

VALIA is an unfunded company, founded in 2026. It operates as a Developer of software for clinical decision support and health analytics. VALIA has not raised any funding yet. The company has 1138 active competitors, including 62 funded and 14 that have exited. Its top competitors include companies like Brainomix, Viz.ai and Infervision.

Company Details

Developer of software for clinical decision support and health analytics. This system integrates with electronic health records to assist physicians during patient consultations. It provides contextual reasoning and suggestions for laboratory testing to reduce clinical variability. The platform operates through a modular rules engine designed to process medical information in real time. It aims to standardize diagnostic pathways and optimize resource utilization within clinical environments.

Key Metrics

Founded Year

2026

Stage

Unfunded

Ranked

1176^th among 1176 competitors

Similar Companies

Brainomix & 1174 more

View VALIA's full profile

VALIA has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of VALIA include Brainomix, Viz.ai and Infervision. Here is the list of Top 10 competitors of VALIA, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Brainomix 2010, Oxford (United Kingdom), Series C	Developer of automated medical imaging software for stroke and lung	$63.3M	Parkwalk, IP Group Hostplus Innovation Fund ... & 18 others	64/100
2nd	Viz.ai 2016, San Francisco (United States), Series D	Developer of an AI-powered platform for care coordination and disease detection	$252M	Insight Partners, DHVC & 17 others	62/100
3rd	Infervision 2016, Beijing (China), Series D	AI-based medical imaging and clinical diagnosis solutions	$213M	Goldman Sachs Investment Partners, CCB trust ... & 19 others	59/100
4th	Airdoc 2015, Beijing (China), Public	Offers decision support solutions	-	Lilly Asia Ventures, Ping An & 7 others	58/100
5th	HEALWELL AI 2012, Toronto (Canada), Acquired	AI-enabled decision support tool for healthcare providers	-	Eight Capital, VRG Capital	57/100
6th	Surgical Safety 2014, New York City (United States), Series B	Provider of AI-based diagnosis and treatment solutions for healthcare organizations	$33.2M	USVP, Sante	55/100
7th	Grand Rounds 2011, San Francisco (United States), Series D	Provider of virtual care, navigation, and support for healthcare needs	$230M	BlackRock, The Carlyle Group & 4 others	55/100
8th	Arine 2017, San Francisco (United States), Series C	Medication management solution for healthcare professionals	$95M	111 West Capital, Katalyst Ventures & 11 others	54/100
9th	Xenter 2017, Draper (United States), Series B	Developer of wireless technologies for interventional medicine	$62.2M	Black Mountain Investment Group	51/100
10th	Predictheon 2019, Barcelona (Spain), Seed	AI-based patient health data analysis software for clinicians	$1.01M	UN I+D+i Tech Transfer, Clave & 2 others	49/100
1176th	VALIA 2026, Unfunded	Developer of software for clinical decision support and health analytics	-	-	-